Dixyrazine
From Wikipedia, the free encyclopedia
![]() |
|
Names | |
---|---|
IUPAC name
(RS)-2-[2-[4-(2-methyl-3-phenothiazin-10-ylpropyl)piperazin-1-yl]ethoxy]ethanol
|
|
Identifiers | |
2470-73-7 ![]() |
|
3D model (Jmol) | Interactive image |
ChemSpider | 16265 ![]() |
ECHA InfoCard | 100.017.811 |
EC Number | 219-591-3 |
KEGG | D07865 ![]() |
PubChem | 17182 |
UNII | 7H368W3AYC ![]() |
|
|
|
|
Properties | |
C24H33N3O2S | |
Molar mass | 427.60272 g/mol |
Pharmacology | |
N05AB01 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
![]() ![]() ![]() |
|
Infobox references | |
Dixyrazine is an antipsychotic. It was first introduced in Germany in 1969 under the name Esucos. It is used as a neuroleptic, anxiolytic and antihistaminic in doses between 12.5 and 75 mg a day.
See also[edit]
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |